Skip to main content

Market Overview

Revance Therapeutics (NASDAQ: RVNC)

30.72 +0.65 (2.16%)

Analyst Ratings

DateResearch FirmActionCurrentPT
2/23/21HC Wainwright & Co.MaintainsBuy35.0
1/08/21NeedhamMaintainsBuy45.0
10/15/20NeedhamMaintainsBuy42.0
4/16/20StifelMaintainsBuy31.0
4/01/20MizuhoMaintainsBuy35.0
3/27/20HC Wainwright & Co.ReiteratesBuy24.0
3/23/20Goldman SachsDowngradesNeutral15.0
2/25/20Piper SandlerReiteratesOverweight40.0
2/25/20NeedhamMaintainsBuy36.0
2/18/20Piper SandlerMaintainsOverweight37.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter